Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31No description of principal activity2024-03-27true0false0false 15598925 2024-03-26 15598925 2024-03-27 2025-03-31 15598925 2023-03-27 2024-03-26 15598925 2025-03-31 15598925 c:Director2 2024-03-27 2025-03-31 15598925 c:EntityHasNeverTraded 2024-03-27 2025-03-31 15598925 c:Micro-entities 2024-03-27 2025-03-31 15598925 c:AuditExempt-NoAccountantsReport 2024-03-27 2025-03-31 15598925 c:FullAccounts 2024-03-27 2025-03-31 15598925 c:PrivateLimitedCompanyLtd 2024-03-27 2025-03-31 15598925 d:PoundSterling 2024-03-27 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 15598925









CLINICAL TELEDERMATOLOGY LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2025

 
CLINICAL TELEDERMATOLOGY LIMITED
REGISTERED NUMBER: 15598925

BALANCE SHEET
AS AT 31 MARCH 2025

2025
£


Current assets
100

Net current assets
 
 
100

Total assets less current liabilities
100


Net assets
100



Capital and reserves
100


Notes


General information

Clinical Teledermatology Limited is a private company limited by shares. The company was incorporated in the United Kingdom and is registered in England and Wales. The registration number is 15598925. The company's registered address is Compass House, Vision Park, Chivers Way, Histon, United Kingdom, CB24 9AD.
The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £.


Average number of employees

The average monthly number of employees, including directors, during the period was 0.

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 8 October 2025.



Edward Stembridge
Director

Page 1